Search Ontology:
ChEBI
alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
- Term ID
- CHEBI:142584
- Synonyms
-
- alpha-NeuNAc-(2->3)-[beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(1-)
- IV4GalNAc,IV3NeuAc-Lc4Cer(1-)
- lacto GalNAc-3'-isoLM1
- Definition
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has subtype
-
Phenotype
Phenotype resulting from alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
Phenotype where environments contain alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
Phenotype modified by environments containing alpha-N-acetylneuraminosyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->4)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(1-)
Human Disease Model